WuXi AppTec Joins This Year’s Dow Jones Sustainability World Index List
Confirms company’s commitment to ESG practices
WuXi AppTec, a provider of R&D- and manufacturing-enabling services in the pharma, biotech and medical device industries, has been included in the 2022 Dow Jones Sustainability World Index (DJSI). This demonstrates the company’s strong performance and commitment to environmental, social, and governance (ESG) initiatives.
The Dow Jones Sustainability World Index features global sustainability leaders as identified by S&P Global through the Corporate Sustainability Assessment (CSA). It represents the top 10% of the largest 2,500 companies in the S&P Global BMI based on long-term economic, environmental, and social criteria. In this evaluation, WuXi AppTec scored three times higher than the industry average and placed in the top 3% among 72 global leading companies reviewed in the Life Sciences Tools & Services sector.
“Inclusion in the Dow Jones Sustainability World Index is a testament to WuXi AppTec’s efforts to integrate ESG into every aspect of our business strategy and operations,” says Edward Hu, vice chairman of WuXi AppTec and chairman of WuXi AppTec’s ESG committee. “We will continue to prioritize our ESG commitments while enabling our customers’ discovery, development, and manufacturing of innovative medicines and groundbreaking therapies for patients around the world.”
Read more about WuXi AppTec’s sustainability efforts here.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
